Abstract
Lenalidomide Induction and Maintenance Maximizes Outcome for Newly Diagnosed Transplant Eligible Myeloma Patients Irrespective of Risk Status: Long-Term Follow-up of the Myeloma XI Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have